Vital Therapies IPO Research Information

Vital Therapies IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Vital Therapies, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Vital Therapies	VTL - NASDAQ	$13.00-$15.00	$12.00	$12.25	4.5 million	4/17/2014
Underwriter(s): BofA Merrill Lynch, Credit Suisse
Co-Manager(s): William Blair, Canaccord Genuity
Industry: Health Care
Filing(s): Filed 2013-10-11 Filed 2014-03-11 Terms Added 2014-04-07

Vital Therapies Quote & Chart - Click for current quote - VTL

About Vital Therapies (adapted from Vital Therapies prospectus):
They are a biotherapeutic company focused on developing a cell-based therapy targeting the treatment of acute liver failure.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "VTL" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.